President of Milestone Scientific (NYSE AMERICAN: MLSS) Comments on Premier Health Contract
Oct. 14, 2020
Milestone Scientific (NYSE American: MLSS) President Arjan Haverhals discusses the importance of the Premier Health contract released today. Milestone Scientific is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS® Dynamic Pressure Sensing technology® platform advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. Visit MLSSinfo.com to learn more.
